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INTRODUCTION:  Osteoﬁbrous  dysplasia  is  a rare  non-neoplastic  disease  that  is almost  exclusive  to pedi-
atric  tibial  diaphysis.  Wide  excision  of the  lesion  is  recommended  to  avoid  recurrence.  However,  such
radical  surgery  will results  in  large  segmental  bone  defects  that  will  require  further  extensive  reconstruc-
tive surgery.  We  report  a novel  approach  of  treating  bone  defect  by  implementing  the  diamond  concept
of bone  healing  using  autologous  bone  marrow  derived  mesenchymal  stem  cells  (BM-MSCs).
PRESENTATION  OF  CASE:  An eight-year-old  Indonesian  male  presented  with  severe  bowing  deformity  of
the left  lower  leg. Radiographic  and  histological  analysis  conﬁrmed  the  diagnosis  of  osteoﬁbrous  dys-
plasia.  A  wide  excision  of  the defect  was  made  leaving  a  critical-sized  bone  defect.  A combination  of
autologous  transplantation  of 50 million  BM-MSCs,  hydroxyapatite  (HA)  granules,  bone  morphogenic
protein  2 (BMP-2)  and  Djoko-Zarov  hybrid  circular  external  ﬁxator  was  used  to treat  the defect.  The  out-
comes  measured  were  subjective  complaints,  functionality  based  on  LEFS  and  radiological  assessments.
DISCUSSION:  Radiographic  assessments  showed  successful  new  bone  tissue  formation  and  integration  of
implanted  HA  granules.  The  external  ﬁxator was removed  at 42 weeks  after  adequate  callus  formation
and  clinical  stability  was  achieved.  The  patient  underwent  progressive  functional  improvements  and
reached  a near  normal  functionality  of  90%  LEFS  at 84 week.  No  therapy  side  effect  or complication  was
reported.
CONCLUSION:  Osteoﬁbrous  dysplasia  was  successfully  excised  without  signs  of  recurrence  after  84-week
follow-up.  Autologous  transplantation  of augmented  BM-MSCs  has  successfully  created  new  normal  bone
tissue  without  causing  any side  effect  and  had  signiﬁcantly  improved  the  patient’s  quality  of life.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Osteoﬁbrous dysplasia is a congenital, non-neoplastic disease
f unknown etiology that is exclusive to the pediatric population.
he most common presenting symptoms of osteoﬁbrous dyspla-
ia is an painless enlargement of the tibia with varying degree of
ibial bowing deformity [1]. Wide excision of the osteoﬁbrous dys-
lasia is indicated for aggressive lesions and severe deformity [2,3].
owever, such approach poses another challenge by leaving a large
egmental defect that requires extensive reconstructive surgery to
estore the volume and strength. The condition is classically man-
ged with vascularized bone graft or bone transport coupled with
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reativecommons.org/licenses/by-nc-nd/4.0/).distraction osteogenesis. However, the outcome may  not always be
satisfactory, and the rate of complications or procedural complexity
negates their use [3,4].
The multipotency of MSCs and its immense potential for treating
orthopaedic cases is well known [5,6]. The osteogenetic capacity of
MSCs is theoretically suitable for treating cases such as bone defect,
where the absence of osteogenesis is one of the main pathoetiol-
ogy. Currently, the application of MSCs for bone defect is limited to
animal study [7,8]. In this case report we present a novel approach
of treating massive bone defect following a wide excision of oste-
oﬁbrous dysplasia by using autologus bone marrow derived MSCs
(BM-MSCs).Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig.1. Preoperative clinical photograph and plain radiography.

















iupine position. Left lower leg marked for surgery. (B) Anteroposterior (left) and late
imited  to the tibia that extends from the diaphysis to distal metaphysis. Accompa
bnormalities.
. Presentation of case
An eight-year-old Indonesian male presented with an obvi-
us bowing deformity of his left lower leg. Physical examination
evealed a painless solid mass with anterolateral bowing deformity
f the left tibia and 5 cm limb shortening. No sign of inﬂam-
ation or skin discoloration was noted (Fig. 1A). X-ray showed
nterolateral tibial shaft bowing that extends to the distal metaph-
sis, bubbled appearance of intracortical osteolytic lesions with no
eriosteal reaction; typical radiographic presentations of osteoﬁ-
rous dysplasia (Fig. 1B). Magnetic resonance imaging (MRI) with
ontrast revealed sclerosis of the internal cortical surface with no
vidence of soft tissue involvement (Fig. 2A). Histopathological
ig. 2. MRI  with contrast and histopathology.
A)  Representative preoperative MRI  of the sagittal (top), axial (middle), and coronal (bo
nvolvement. (B) Analysis of core needle biopsy showed features consistent with osteoﬁbght) X-rays showing typical presentations of osteoﬁbrous dysplasia. The lesion was
ﬁbular bowing was  evident. No observable periosteal reaction, knee or ankle joint
analysis was consistent with osteoﬁbrous dysplasia, showing C-
shaped bony spicules with immature bone trabeculae lined with
active osteoblasts (Fig. 2B). Daily functionality measured by Lower
Extremity Functional Scale (LEFS) [9] was 11.25%. Routine hema-
tology and urine test results were within normal limits.
The patient was diagnosed with left tibial osteoﬁbrous dysplasia
and planned for a wide excision of the tumor followed by autolo-
gous transplantation BM-MSCs in a two-stage procedure. Tumor
excision, external ﬁxation, and bone marrow harvest were con-
ducted in the ﬁrst stage. Auto-transplantation of BM-MSCs and ﬁnal
adjustments of external ﬁxator were performed in the second stage.
A wide excision lesion was  performed, leaving a critical-size
bone defect. The procedure was followed by ﬁbular osteotomy,
ttom) plane. Sclerosis of the internal cortical surface is evident with no soft tissue
rous dysplasia (hematoxylin and eosin staining; 10× magniﬁcation).
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P l HA granules and blurring of the osteotomy lines. Good tibial alignment and adequate










































Summary of post-operative follow-up.
Time Clinical complaints VAS LEFS Tiedeman/Lane-
Sandhu
Week 4 Slight pain upon active
movement
1 42.5% 6/2
Week 8 Slight pain upon active
movement
1 42.25% 6/2
Week 12 Slight pain upon active
movement
1 42.25% 6/2
Week 16 None 0 50% 6/2
Week 36 None 0 66.25% 9/3
Week 42 None 0 66.25% 9/3
Week 84 None 0 90% 12/4ig. 3. Post-operative radiographic progressions of bone healing.
rogressive new bone tissue formation evidenced by the less noticeable individua
allus  formation was achieved at 42 week. No radiographic sign of recurrence was 
oft tissue closure and stabilization using Djoko-Zarov hybrid cir-
ular external ﬁxator. The external ﬁxation was maintained for 28
ays throughout in vitro BM-MSCs cultivation. Thirty milliliters of
one marrow was aspirated from the posterior iliac crest into a
ontainer pre-ﬁlled with 5000 U/mL of heparin. The aspirate was
iluted with 30 mL  of phosphate-buffered saline (PBS) and cen-
rifuged at 3000 rpm for 30 min  in room temperature. The buffy
oat was washed and transferred into culture ﬂask with Dulbecco’s
odiﬁed Eagle Medium (DMEM; Gibco, Grand Island, New York)
upplemented with 10% fetal bovine serum. Isolated cells were
ncubated in 37 ◦C at 20% O2 and 5% CO2.
The ﬁrst medium change was performed on day 5 with thor-
ugh washing with PBS to discard ﬂoaters and debris. The cells
ere further cultured with routine medium change every 2–3 days
ntil reaching conﬂuency. Upon reaching conﬂuence, the plastic-
dherent ﬁbroblastic cells were trypsinized and characterized with
owcytometry (FACSCaliburTM, Franklin Lakes, NJ). More than 99%
f the cells expressed CD 73, CD105, while none expressed HLA-
R, CD14, CD19, CD34 and CD45. These ﬁndings conﬁrmed that
he plastic-adherent cells were of mesenchymal stromal origin.
he BM-MSCs were sub-cultured into ﬁrst passage with routine
edium change every 2–3 days.
Subsequent sub-cultures were performed whenever cell con-
uence was achieved. After 28 days all cultured BM-MSCs were
rypsinized, washed, counted, and suspended in freshly obtained
atient’s serum on the day of transplantation. Sterility tests were
onducted thrice; aspirated bone marrow before passage zero (P0),
sed medium on day 7 of culture, and the last medium change prior
o transplantation. All tissue culture procedures were performed in
MP  certiﬁed tissue culture laboratory. Approximately ﬁfty million
M-MSCs were transplanted back to ﬁll to the bone defect during
he second stage procedure in December 2012. The defect was ﬁrst
lled with 5 g/cm defect of hydroxyapatite granules (HA; Bongros®-
A, Bioalpha, Seungnam, Korea) and 1.66 mg/cm defect of bone
orphogenetic protein-2 (BMP-2; Novosis, CGBio, Seoul, Korea).
M-MSCs were carefully introduced evenly throughout the defect
nd the external ﬁxator was adjusted accordingly. The patient suf-
ered no acute complication and was discharged on the seventh day.
he outcomes measured were subjective complaints, functionality
ased on LEFS, and radiological assessments based on Tiedeman
10] and Lane-Sandhu scoring system [11].
Partial weight bearing was allowed at four weeks and full
eight at eight. Limb length discrepancy was corrected and theVAS–visual analog scale.
LEFS–lower extremity functional scale.
external frame maintained normal tibial mechanical axis. Thus no
frame manipulation was performed on the external hybrid frame
throughout the post-operative period. With evident callus and bone
stability the external ﬁxator was  removed at 42 weeks (Fig. 3).
Pin tract wounds were managed with regular gauze change and
topical antibiotic. No signiﬁcant complaints or complications were
reported during the 84 weeks follow-up (Fig. 4). The patient’s LEFS
gradually improved, especially after the external frame removal.
Since then, the patient was  able to carry out daily activities with
little to no problem and regularly participated in high-intensity
sport. Progressions of post-operative outcomes are summarized in
Table 1.
3. Discussion
A widely acceptable view for managing osteoﬁbrous dysplasia
is to postpone surgical therapy until skeletal maturity is reached
and to avoid extensive surgery to avoid complications. We  dis-
cuss several reasons why  wide excision was performed in our
patient. The general recommendation to avoid operation before
the skeletal maturity was due to the high recurrence rate of osteoﬁ-
brous dysplasia following surgical intervention [1,12,13]. An Italian
study reported a 64% rate of recurrence (16 out of 25) in patients
who underwent curettage or subperiosteal tangential resection
[1]. Seven of out those 16 patients had second recurrence after
non-wide excision reoperation was done. In contrast, those who
underwent wide extraperiosteal resection did not have any recur-
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tig. 4. Clinical appearance at 84 weeks.
traight tibial mechanical axis was achieved and allowed normal weight distributio
ble  to stand erect for an extended period.
ing osteolytic lesions. A similar trend was also observed in a
etrospective study conducted in England [3].
Additionally, there is a small chance but high risks association
etween osteoﬁbrous dysplasia and the malignant adamantinoma.
azelbag et al. reported 3 patients with classical adamanti-
oma were previously diagnosed with osteoﬁbrous dysplasia-like
damantinoma [14]. In a review of 16 patients, Lee et al. reported
 cases of deﬁnitive adamantinoma that was previously diagnosed
ith osteoﬁbrous dysplasia by the same pathologist [3]. In another
atient, histopathological diagnoses of both ﬁbrous dysplasia and
damantinoma were made from the same curettage specimen. The
uthor advocated the use of radical extraperiosteal excision for all
ases of osteoﬁbrous dysplasia, contrasting previous recommen-
ations. Another basis for a wide excision in our patient was the
everity of his bowing deformity.
Corrective osteotomy may  not satisfactorily correct the
echanical axis deviation, and carries the risks for recurrence
nless en blocexcision was made. Circular external ﬁxator was cho-
en for superior mechanical stability and the versatility to be easily
anipulated if adjustments are needed during the post-operative
eriod. We  believed prompt correction of the deformed limb is of a
reat importance to restore the patient’s quality of life, irrespective
f skeletal maturity.
Limb salvage procedures often results in large bone defect. Sev-
ral options for reconstruction includes arthrodesis, bone graft,
one transfer, bone transport or mesenchymal stem cell implan-
ation. Arthrodesis creates a stable, painless and durable limb,he left ankle. With no leg length discrepancy or joint abnormality, the patient was
however it immobilizes joints and cause limb inequality. Osteoar-
ticular or bulk allografts are subjected to high rates of early
complications such as infection, fracture, nonunion, immunologic
complications or disease transmission [15]. Vascularized bone
grafts are suitable for large skeletal defects. With rapid incorpora-
tion, vascularized bone graft creates stronger construct secondary
to graft hypertrophy and does not cause adverse immunologic
response. However it requires longer operation, donor and sur-
gical site morbidity. Bone transfer has little to no osteoinductive
properties and there are limited reports on this technique [16]. Dis-
traction osteogenesis or bone transport requires extended period
of treatment and high patient compliance level. It causes more
complications and frequently results in poor functional outcome
[17].
Our patient suffered from critical-sized bone defect following
the segmental bone resection. Deﬁned as the loss of bone length
2–2.5 times the diameter of affected bone, which will not heal
spontaneously during the lifetime of the patient [18]. Thus, we
utilized the osteogenic potency of MSCs to treat the patient. The
combination of allogeneic or autologous MSCs with synthetic bone
substitute (hydroxyapatite-tricalcium phosphate) was  found to
enhance bone healing in canines with critical-sized bone defect [7].
Greater osteogenic activity was found in rat calvarial defects treated
with BM-MSCs, platelet-rich plasma (PRP) and biphasic calcium
phosphate (BCP) bone ceramic, compared to PRP and BCP alone
[8]. Data from animal experiments exploring MSCs for treating
bone defect were encouraging. The well-known diamond concept
 –  O
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mphasized importance of osteogenic, osteoconductive, osteoin-
uctive and stable mechanical environment for fracture healing
19]. In this study, each component was represented by BM-MSCs,
A granules, BMP-2 and Djoko-Zarov hybrid frame respectively. HA
ranules will served as the main platform for osteogenic BM-MSCs
xpansion, that is enhanced by the BMP-2 [20]. We hypothesized
hat such combination is key for a successful management of large
one defects.
During the ﬁrst three post-operative weeks the patient was
nable to squat, climb stairs, run, make sharp turns or hop. With less
ain and adaptation to the external frame, the patient’s LEFS gradu-
lly improved within the next 12 weeks. The circular frame installed
istal from the knee restricted full knee ﬂexion. Thus the patient
as unable to perform full squat until the external frame removal.
adiographic improvements were signiﬁed by the presence of
hicker callus forming within the more radiopaque HA granules.
ess distinction of individual HA granules and blurring of the two
orizontal osteotomy lines were progressively more evident with
ubsequent radiography. The external frame was removed at week
2 based on sufﬁcient callus formation; 75% or 3 based on Lane-
andhu scoring system, no clinical complaint and ability for full
eight bearing. Signiﬁcant improvements of LEFS were observed
fter the external frame removal. The patient quickly gained con-
dence and engaged brisk walking. Near-normal function of 90%
EFS was achieved at 84 week with improved radiographic ﬁndings.
t this stage, the patient routinely played football with no com-
laints of bone pain or joint stiffness. Series of X-rays showed no
vidence of recurrent osteolytic lesions. This ﬁnding supports the
ide extraperiosteal excision approach for treating osteoﬁbrous
ysplasia. No osteomyelitis, immunogenic, or other signiﬁcant side
ffects has occurred.
This report lacks histological results from the newly formed
one tissue. Such information is valuable to assess the quality
nd to detect any subtle morphogenic differences between nor-
al  bone and bone made by the MSC, HA and BMP-2 combination.
uch study was not performed due to the newly formed tibia that
as not remodeled into normal shaft diameter and shape. Addi-
ionally, obtaining histological sample at this stage may  risk is
tructural compromise or infection. We  expect to observe contin-
ous anatomical improvements through bone remodeling in the
ourse of several years. There were several limitations to the tech-
ique used. Although distraction osteogenesis was not carried out,
he application of cumbersome circular external ﬁxation was still
equired. Additionally, the risk of side effect from MSC  therapy has
ot been fully described. Thus, our patient was subjected to risks
f secondary malignancy or unfavorable immunologic response.
To our knowledge, this is the ﬁrst report for combined therapy
f BM-MSCs, HA, and BMP-2 for treating bone defect in human.
esults presented in this report are in favor of MSCs-based ther-
py for critical-sized bone defect. Routine autologous MSCs therapy
ay avoid the need of bone graft or bone transport surgery that
equires exceptional patient compliance throughout distraction
steogenesis and rehabilitation period. It is important to recog-
ize that the applications of this novel approach may  potentially
e extended for other orthopaedic complications such as nonunion.
owever, results from larger controlled clinical trial are required
o validate our ﬁndings before it can be considered as a standard
reatment option.
. ConclusionIn conclusion, osteoﬁbrous dysplasia in an eight-year-old
atient was successfully excised without recurrence after 84 week.
his ﬁnding supports newer recommendations to widely excise
ny case of osteoﬁbrous dysplasia. Autologous transplantation ofPEN  ACCESS
gery Case Reports 17 (2015) 106–111
BM-MSCs combined with HA, BMP-2 and external ﬁxation has suc-
cessfully created new normal bone tissue and returned normal
functionality of the patient. This novel approach has satisfacto-
rily managed the critical-sized bone defect with no signiﬁcant side
effects or complications.
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